姜黄素调控唾液腺肿瘤细胞增殖和凋亡的机制探讨

doi:10.19439/j.sjos.2022.05.007

上海口腔医学 ›› 2022, Vol. 31 ›› Issue (5): 483-490.doi: 10.19439/j.sjos.2022.05.007

姜黄素调控唾液腺肿瘤细胞增殖和凋亡的机制探讨

杜洪亮, 何等旗, 王佳俐, 车银富, 闫庆涵

兰州大学第一医院口腔颌面外科,甘肃兰州 730000

收稿日期:2021-06-04 修回日期:2021-08-03 出版日期:2022-10-25 发布日期:2022-11-01
通讯作者: 何等旗,E-mail：qingling0633@163.com
作者简介:杜洪亮（1987-）,男,硕士,副主任医师,E-mail：duhongliang2022@sina.com
基金资助:
兰州大学第一医院院内基金（ldyyyn2020-55）

Curcumin targeting miR-155-5p/TP53INP1axis induced oxidative stress to regulate salivary gland tumor cell proliferation, apoptosis

DU Hong-liang, HE Deng-qi, WANG Jia-Li, CHE Yin-fu, YAN Qing-han

Department of Oral and Maxillofacial Surgery, The First Hospital of Lanzhou University. Lanzhou 730000, Gansu Province, China

Received:2021-06-04 Revised:2021-08-03 Online:2022-10-25 Published:2022-11-01

摘要/Abstract

摘要： 目的: 探讨姜黄素靶向miR-155-5p/TP53INP1轴诱导氧化应激调控唾液腺肿瘤细胞增殖和凋亡的机制。方法: A253细胞加入姜黄素及转染miR-155-5p mimic和（或）pcDNA3.1-TP53INP1,共同培养。采用CCK-8法检测细胞增殖;流式细胞术检测细胞凋亡;划痕实验检测细胞迁移能力;双荧光素酶报告实验验证miR-155-5p与TP53INP1之间的靶向关系;qRT-PCR检测细胞miR-155-5p、TP53INP1mRNA的表达;Western印迹法检测细胞TP53INP1、Caspase8、Caspase3、Bcl-2、Bax蛋白表达;ELISA法检测细胞SOD、Gpx、MDA含量。采用SPSS 22.0软件包对数据进行统计学分析。结果: 双荧光素酶报告实验证实,TP53INP1是miR-155-5p的下游靶向调控分子;与DMSO组相比,姜黄素组细胞凋亡、Caspase8、Caspase3、Bax蛋白表达及TP53INP1表达显著增加,Bcl-2蛋白表达、miR-155-5p mRNA及划痕迁移细胞数显著降低（P<0.05）;与姜黄素+miR-155-5p mimic组相比,姜黄素+pcDNA3.1-TP53INP1组、姜黄素+miR-155-5p mimic+pcDNA3.1-TP53INP1组细胞凋亡、Caspase8、Caspase3、Bax蛋白表达显著增加,Bcl-2蛋白表达显著升高（P<0.05）,姜黄素+pcDNA3.1-TP53INP1组SOD、GSH-PX活性及划痕迁移细胞数显著降低,MDA含量显著升高（P<0.05）。结论: 姜黄素抑制A253细胞增殖,促进A253细胞凋亡,其机制可能与靶向miR-155-5p/TP53INP1轴诱导氧化应激调控有关。

关键词: 唾液腺, 恶性肿瘤, 姜黄素, miR-155-5p, 氧化应激

Abstract: PURPOSE: To investigate the mechanism of curcumin targeting miR-155-5p/TP53INP1 axis to induce oxidative stress to regulate salivary gland tumor cell proliferation and apoptosis. METHODS: A253 cells were cultured by adding curcumin and transfected with miR-155-5p mimic and/or pcDNA3.1-TP53INP1. Cell proliferation was detected by CCK-8 assay cell apoptosis was detected by flow cytometry, cell migration ability was detected by scratch test. The targeting relationship between miR-155-5p and TP53INP1 was verified by dual luciferase reporter assay. miR-155-5p, TP53INP1 mRNA expression was detected by qRT-PCR. Western blot was performed to detect expression of TP53INP1, Caspase8, Caspase3, Bcl-2, Bax protein; and ELISA was used to determine SOD, Gpx, and MDA content. Statistical analysis was performed using SPSS 22.0 software package. RESULTS: Dual luciferase reporter assay confirmed that TP53INP1 was a downstream target regulatory molecule of miR-155-5p. Compared with DMSO group, cell apoptosis, Caspase8, Caspase3, Bax protein expression and TP53INP1 expression were significantly increased in curcumin group, while Bcl-2 protein expression, miR-155-5p mRNA and number of cell migration were significantly decreased(P<0.05). Compared with curcumin + miR-155-5p mimic group, cell apoptosis, Caspase8, Caspase3, Bax protein expression was significantly increased in curcumin + pcDNA3.1-TP53INP1 group and curcumin + miR-155-5p mimic + pcDNA3.1-TP53INP1 group; Bcl-2 protein expression was significantly increased(P<0.05), SOD, GSH-PX activities and number of cell migration were significantly decreased and MDA content was significantly increased in curcumin+pcDNA3.1-TP53INP1 group (P<0.05). CONCLUSIONS: Curcumin inhibited A253 cell proliferation and promoted A253 cell apoptosis. The mechanism may be related to targeting miR-155-5p/TP53INP1 axis to induce oxidative stress regulation.

Key words: Salivary gland, Malignant neoplasms, Curcumin, miR-155-5p, Oxidative stress

中图分类号:

R739.8

杜洪亮, 何等旗, 王佳俐, 车银富, 闫庆涵. 姜黄素调控唾液腺肿瘤细胞增殖和凋亡的机制探讨[J]. 上海口腔医学, 2022, 31(5): 483-490.

DU Hong-liang, HE Deng-qi, WANG Jia-Li, CHE Yin-fu, YAN Qing-han. Curcumin targeting miR-155-5p/TP53INP1axis induced oxidative stress to regulate salivary gland tumor cell proliferation, apoptosis[J]. Shanghai Journal of Stomatology, 2022, 31(5): 483-490.

参考文献

[1] Abdel Razek AAK, Mukherji SK.Imaging of posttreatment salivary gland tumors[J]. Neuroimaging Clin N Am, 2018, 28(2):199-208.
[2] Sood S, McGurk M, Vaz F. Management of salivary gland tumours: united kingdom national multidisciplinary guidelines[J]. J Laryngol Otol, 2016, 130(S2): S142-S149.
[3] Dillon PM, Chakraborty S, Moskaluk CA, et al.Adenoid cystic carcinoma: a review of recent advances, molecular targets, and clinical trials[J]. Head Neck, 2016, 38(4): 620-627.
[4] Laurie SA, Ho AL, Fury MG, et al.Systemic therapy in the management of metastatic or locally recurrent adenoid cystic carcinoma of the salivary glands: a systematic review[J]. Lancet Oncol, 2011, 12(8): 815-824.
[5] Andreasen S.Molecular features of adenoid cystic carcinoma with an emphasis on microRNA expression[J]. APMIS, 2018, 126(Suppl 140): 7-57.
[6] Tutar Y. miRNA and cancer; computational and experimental approaches[J]. Curr Pharm Biotechnol, 2014, 15(5):429-433.
[7] Liu L, Hu Y, Fu J, et al.MicroRNA155 in the growth and invasion of salivary adenoid cystic carcinoma[J]. J Oral Pathol Med, 2013, 42(2): 140-147.
[8] 王学敏, 庞欣, 王晓蒙, 等. 姜黄素通过TGF-β/Smads信号通路对肾缺血再灌注后肾小管间质纤维化抑制作用[J]. 重庆医科大学学报,2021,46(10):1158-1162.
[9] Mirzaei H, Shakeri A, Rashidi B, et al.Phytosomal curcumin: a review of pharmacokinetic, experimental and clinical studies[J]. Biomed Pharmacother, 2017, 85:102-112.
[10] Marjaneh RM, Rahmani F, Hassanian SM, et al.Phytosomal curcumin inhibits tumor growth in colitis-associated colorectal cancer[J]. J Cell Physiol, 2018, 233(10): 6785-6798.
[11] Yang X, Wu JS, Li M, et al.Inhibition of DEC2 is necessary for exiting cell dormancy in salivary adenoid cystic carcinoma[J]. J Exp Clin Cancer Res, 2021, 40(1): 169-182.
[12] Castello A, Olivari L, Lopci E.Adenoid cystic carcinoma: focus on heavy ion therapy and molecular imaging[J]. Am J Nucl Med Mol Imaging, 2018, 8(1): 1-14.
[13] Dantas AN, Morais EF, Macedo RA, et al.Clinicopathological characteristics and perineural invasion in adenoid cystic carcinoma: a systematic review[J]. Braz J Otorhinolaryngol, 2015, 81(3): 329-335.
[14] 禚昌红, 张道伟, 司国民. 姜黄素及其纳米制剂抗肝癌分子机制研究进展[J].中国实验方剂学杂志, 2021, 27(10): 184-192.
[15] Wang WW, Chen B, Lei CB, et al.miR-582-5p inhibits invasion and migration of salivary adenoid cystic carcinoma cells by targeting FOXC1[J]. Jpn J Clin Oncol, 2017, 47(8): 690-698.
[16] Bayraktar R, Van Roosbroeck K. miR-155 in cancer drug resistance and as target for miRNA-based therapeutics[J]. Cancer Metastasis Rev, 2018, 37(1): 33-44.
[17] Hu Y, Wu D, Feng X, et al.Research on the effect of interfering with miRNA-155 on triple-negative breast cancer cells[J]. Genes Genomics, 2022, 44(9):1117-1124.
[18] Al-Haidari A, Algaber A, Madhi R, et al.MiR-155-5p controls colon cancer cell migration via post-transcriptional regulation of Human Antigen R (HuR)[J]. Cancer Lett, 2018, 421: 145-151.
[19] Wang J, Guo J, Fan H.MiR-155 regulates the proliferation and apoptosis of pancreatic cancer cells through targeting SOCS3[J]. Eur Rev Med Pharmacol Sci, 2020, 24(24): 12625-12625.
[20] Due H, Svendsen P, Bødker JS, et al.miR-155 as a biomarker in B-cell malignancies[J]. Biomed Res Int, 2016, 2016: 9513037.
[21] Zhao XQ, Tang H, Yang J, et al.MicroRNA-15a-5p down-regulation inhibits cervical cancer by targeting TP53INP1 in vitro[J]. Eur Rev Med Pharmacol Sci, 2019, 23(19): 8219-8229.
[22] Wang Y, Sun H, Zhang D, et al.TP53INP1 inhibits hypoxia-induced vasculogenic mimicry formation via the ROS/snail signalling axis in breast cancer[J]. J Cell Mol Med, 2018, 22(7): 3475-3488.
[23] Liu F, Kong X, Lv L, et al.MiR-155 targets TP53INP1 to regulate liver cancer stem cell acquisition and self-renewal[J]. FEBS Lett, 2015, 589(4): 500-506.
[24] Liu F, Kong X, Lv L, et al.TGF-β1 acts through miR-155 to down-regulate TP53INP1 in promoting epithelial-mesenchymal transition and cancer stem cell phenotypes[J]. Cancer Lett, 2015, 359(2): 288-298.
[25] He J, Jiang BH.Interplay between reactive oxygen species and microRNAs in cancer[J]. Curr Pharmacol Rep, 2016, 2(2): 82-90.

姜黄素调控唾液腺肿瘤细胞增殖和凋亡的机制探讨

Curcumin targeting miR-155-5p/TP53INP1axis induced oxidative stress to regulate salivary gland tumor cell proliferation, apoptosis

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	丁泰然, 居来提·吐尔逊, 姚志涛, 买买提吐逊·吐尔地. 经口机器人辅助咽后淋巴结清扫术治疗头颈部恶性肿瘤的疗效及预后因素的Cox模型分析[J]. 上海口腔医学, 2023, 32(5): 508-512.
[2]	刘畅, 吴琼, 陈少华, 徐涛, 刘亮, 张凯. 数字化精准骨穿刺指导颌骨切除范围的可行性研究[J]. 上海口腔医学, 2023, 32(5): 519-524.
[3]	朱文静, 余强, 陶晓峰, 王韶颖, 田涛, 张春叶. 43例小唾液腺癌在多形性腺瘤中的影像学表现[J]. 上海口腔医学, 2023, 32(3): 255-260.
[4]	白晗, 刘涵, 朱蕾, 刘超, 李楠, 肖晶. POLQ表达降低对SACC-83细胞DNA损伤敏感性的影响[J]. 上海口腔医学, 2023, 32(2): 120-125.
[5]	许佳丽, 孙衎达, 朱雅琦. 葡萄籽提取物对慢性牙周炎合并动脉粥样硬化大鼠氧化应激及主动脉病理变化的影响[J]. 上海口腔医学, 2022, 31(6): 597-601.
[6]	吕欢, 熊屏, 张蔚蒨, 龚霞, 李佳, 丁昂昂. 多模态超声对唾液腺肿瘤的鉴别诊断价值评价[J]. 上海口腔医学, 2022, 31(4): 384-388.
[7]	夏佳琳, 曾奕玮, 赵小妹, 侯黎莉. 心理干预对头颈部恶性肿瘤患者负性情绪及生活质量影响的meta分析[J]. 上海口腔医学, 2022, 31(3): 330-336.
[8]	高洁, 姜雅萍, 马康傑, 赵保东, 邓婧. PRRX1对唾液腺腺样囊性癌细胞自噬的影响[J]. 上海口腔医学, 2021, 30(5): 477-480.
[9]	孙娟, 张海峰, 唐雯, 刘希鹏, 赵安达. 口腔颌面恶性肿瘤合并糖尿病患者围术期营养状况调查分析[J]. 上海口腔医学, 2021, 30(3): 306-311.
[10]	马婧, 李继扬, 杨巧珍, 白昱, 张程, 孙红英. 不同功率密度的姜黄素-光动力疗法对白色念珠菌生物膜的影响[J]. 上海口腔医学, 2020, 29(5): 456-461.
[11]	王震, 孙扬, 陈佳露, 龚逸明. 姜黄素对环孢素A诱导激活的大鼠牙龈成纤维细胞TGF-β1/Smad3通路的抑制作用[J]. 上海口腔医学, 2020, 29(4): 359-364.
[12]	王菲, 邱丽华, 庞谅, 万书良. 重庆地区ABO血型与口腔颌面部恶性肿瘤关系的研究[J]. 上海口腔医学, 2020, 29(2): 179-182.
[13]	米靖, 于博, 于雅琼, 李晓琳, 杜亚鑫, 仇丽鸿. 白藜芦醇通过SOCS-1蛋白抑制牙髓卟啉单胞菌脂多糖诱导的氧化应激反应[J]. 上海口腔医学, 2019, 28(3): 237-240.
[14]	蒋琪, 朱冰玉, 德维, 周雄文. 姜黄素对去势骨质疏松大鼠下颌骨和股骨EZH2基因表达的影响[J]. 上海口腔医学, 2019, 28(3): 241-245.
[15]	张海峰, 张美芳, 赵安达, 李烿烿. 口腔恶性肿瘤术后患者放疗前营养状况与膳食营养素摄入的相关性研究[J]. 上海口腔医学, 2019, 28(3): 288-292.